Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives

US Patent 12404237 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →